Do you want to read an article? Please log in or register.
Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration
Macular Diseases
Related content
COMMENTED
Macular Diseases
Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: AREDS2 Report 34
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Duic C, Vance E, Agrón E, Keenan TDL, AREDS2 Research Group
doi: 10.1016/j.oret.2024.11.006
RECOMMENDED
Macular Diseases
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Berni A, Coletto A, Li J, Shen M, Bandello F, Reibaldi M, Borrelli E
doi: 10.1016/j.oret.2025.01.011
Macular Diseases
Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study
Acta Ophthalmol
Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I
doi: 10.1111/aos.17534
Macular DiseasesRetinal Diseases
Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration
Br J Ophthalmol
Olivieri C, Neri G, Ricardi F, Gelormini F, Fai A, Parisi G, Marolo P, Viggiano P, Boscia F, Reibaldi M, Borrelli E
doi: 10.1136/bjo-2025-328225
Macular Diseases
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
Br J Ophthalmol
Borrelli E, Foti C, Ulla L, Porreca A, Introini U, Grassi MO, Viggiano P, Peronetti M, Toscani R, Boscia G, Termite AC, Gennaro C, Marolo P, Boscia F, Bandello F, Reibaldi M
doi: 10.1136/bjo-2024-326152
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol
Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, Muni RH
doi: 10.1001/jamaophthalmol.2025.1455
Macular Diseases
Dynamic Risk of Systemic Complement Activation With Time to Progression to Advanced Age-Related Macular Degeneration
JAMA Ophthalmol
Lynch AM, Grove NC, Wagner BD, Palestine AG, Holers VM, Frazer-Abel AA, Gnanaraj R, Lisker-Cervantes A, Patnaik JL, de Carlo Forest TE, Auer EA, McReynolds AJ, Mathias MT, Manoharan N, Rodriquez De Cordoba S, Mandava N
doi: 10.1001/jamaophthalmol.2025.1608
Macular Diseases
Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Clin Exp Ophthalmol
Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA
doi: 10.1111/ceo.14559
Macular Diseases
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Br J Ophthalmol
Vu TA, Fenwick EK, Man REK, Thakur S, Tan ACS, Cheung CMG, Gupta P, Lamoureux EL
doi: 10.1136/bjo-2024-325713